Attach to Form 990 or Form 990-EZ.
Go to
www.irs.gov/Form990 for instructions and the latest information.
| (i) Name of supported organization | (ii) EIN | (iii) Type of organization (described on lines 1- 10 above (see instructions)) | (iv) Is the organization listed in your governing document? | (v) Amount of monetary support (see instructions) | (vi) Amount of other support (see instructions) | |
|---|---|---|---|---|---|---|
| Yes | No | |||||
|
Total |
||||||
Calendar year
(or fiscal year beginning in)
![]() |
(a) 2019 | (b) 2020 | (c) 2021 | (d) 2022 | (e) 2023 | (f) Total | |
|---|---|---|---|---|---|---|---|
| 1 | Gifts, grants, contributions, and membership fees received. (Do not include any "unusual grant.") .. | 0 | |||||
| 2 | Tax revenues levied for the organization's benefit and either paid to or expended on its behalf .... | 0 | |||||
| 3 | The value of services or facilities furnished by a governmental unit to the organization without charge.. | 0 | |||||
| 4 | Total. Add lines 1 through 3 | 0 | 0 | 0 | 0 | 0 | 0 |
| 5 | The portion of total contributions by each person (other than a governmental unit or publicly supported organization) included on line 1 that exceeds 2% of the amount shown on line 11, column (f) .. | 0 | |||||
| 6 | Public support. Subtract line 5 from line 4. | 0 | |||||
Calendar year
(or fiscal year beginning in)
![]() |
(a) 2019 | (b) 2020 | (c) 2021 | (d) 2022 | (e) 2023 | (f) Total | |
|---|---|---|---|---|---|---|---|
| 7 | Amounts from line 4.. | 0 | 0 | 0 | 0 | 0 | 0 |
| 8 | Gross income from interest, dividends, payments received on securities loans, rents, royalties and income from similar sources... | 0 | |||||
| 9 | Net income from unrelated business activities, whether or not the business is regularly carried on.. | ||||||
| 10 | Other income. Do not include gain or loss from the sale of capital assets (Explain in Part VI.).. | 0 | 0 | 0 | 0 | 0 | 0 |
| 11 | Total support. Add lines 7 through 10 | 0 | |||||
Calendar year (or fiscal
year beginning in) ![]() |
(a) 2019 | (b) 2020 | (c) 2021 | (d) 2022 | (e) 2023 | (f) Total | |
|---|---|---|---|---|---|---|---|
| 1 | Gifts, grants, contributions, and membership fees received. (Do not include any "unusual grants.") . | 0 | |||||
| 2 | Gross receipts from admissions, merchandise sold or services performed, or facilities furnished in any activity that is related to the organization's tax-exempt purpose | 0 | |||||
| 3 | Gross receipts from activities that are not an unrelated trade or business under section 513 ..... | 0 | |||||
| 4 | Tax revenues levied for the organization's benefit and either paid to or expended on its behalf... | 0 | |||||
| 5 | The value of services or facilities furnished by a governmental unit to the organization without charge | 0 | |||||
| 6 | Total. Add lines 1 through 5 | 0 | 0 | 0 | 0 | 0 | 0 |
| 7a | Amounts included on lines 1, 2, and 3 received from disqualified persons | 0 | 0 | 0 | 0 | 0 | 0 |
| b | Amounts included on lines 2 and 3 received from other than disqualified persons that exceed the greater of $5,000 or 1% of the amount on line 13 for the year. | 0 | 0 | 0 | 0 | 0 | 0 |
| c | Add lines 7a and 7b.. | 0 | 0 | 0 | 0 | 0 | 0 |
| 8 | Public support. (Subtract line 7c from line 6.) | 0 | |||||
Calendar year
(or fiscal year beginning in)
![]() |
(a) 2019 | (b) 2020 | (c) 2021 | (d) 2022 | (e) 2023 | (f) Total | |
|---|---|---|---|---|---|---|---|
| 9 | Amounts from line 6... | 0 | 0 | 0 | 0 | 0 | 0 |
| 10a | Gross income from interest, dividends, payments received on securities loans, rents, royalties and income from similar sources.. | 0 | |||||
| b | Unrelated business taxable income (less section 511 taxes) from businesses acquired after June 30, 1975. | 0 | |||||
| c | Add lines 10a and 10b. | 0 | 0 | 0 | 0 | 0 | 0 |
| 11 | Net income from unrelated business activities not included on line 10b, whether or not the business is regularly carried on. | 0 | |||||
| 12 | Other income. Do not include gain or loss from the sale of capital assets (Explain in Part VI.) .. | 0 | 0 | 0 | 0 | 0 | 0 |
| 13 | Total support. (Add lines 9, 10c, 11, and 12.).. | 0 | 0 | 0 | 0 | 0 | 0 |
| Section A - Adjusted Net Income | (A) Prior Year |
(B) Current Year (optional) |
||||
| 1 | Net short-term capital gain | 1 | ||||
| 2 | Recoveries of prior-year distributions | 2 | ||||
| 3 | Other gross income (see instructions) | 3 | ||||
| 4 | Add lines 1 through 3 | 4 | ||||
| 5 | Depreciation and depletion | 5 | ||||
| 6 | Portion of operating expenses paid or incurred for production or collection of gross income or for management, conservation, or maintenance of property held for production of income (see instructions) | 6 | ||||
| 7 | Other expenses (see instructions) | 7 | ||||
| 8 | Adjusted Net Income (subtract lines 5, 6 and 7 from line 4) | 8 | ||||
| Section B - Minimum Asset Amount | (A) Prior Year |
(B) Current Year (optional) |
||||
| 1 | Aggregate fair market value of all non-exempt-use assets (see instructions for short tax year or assets held for part of year): | 1 | ||||
| a | Average monthly value of securities | 1a | ||||
| b | Average monthly cash balances | 1b | ||||
| c | Fair market value of other non-exempt-use assets | 1c | ||||
| d | Total (add lines 1a, 1b, and 1c) | 1d | ||||
| e |
Discount claimed for blockage or other factors (explain in detail in Part VI): |
|||||
| 2 | Acquisition indebtedness applicable to non-exempt use assets | 2 | ||||
| 3 | Subtract line 2 from line 1d | 3 | ||||
| 4 | Cash deemed held for exempt use. Enter 0.015 of line 3 (for greater amount, see instructions). | 4 | ||||
| 5 | Net value of non-exempt-use assets (subtract line 4 from line 3) | 5 | ||||
| 6 | Multiply line 5 by 0.035 | 6 | ||||
| 7 | Recoveries of prior-year distributions | 7 | ||||
| 8 | Minimum Asset Amount (add line 7 to line 6) | 8 | ||||
| Section C - Distributable Amount | Current Year | |||||
| 1 | Adjusted net income for prior year (from Section A, line 8, Column A) | 1 | 0 | |||
| 2 | Enter 85% of line 1 | 2 | 0 | |||
| 3 | Minimum asset amount for prior year (from Section B, line 8, Column A) | 3 | 0 | |||
| 4 | Enter greater of line 2 or line 3 | 4 | 0 | |||
| 5 | Income tax imposed in prior year | 5 | 0 | |||
| 6 | Distributable Amount. Subtract line 5 from line 4, unless subject to emergency temporary reduction (see instructions) | 6 | 0 | |||
| Section D - Distributions | Current Year | |
|---|---|---|
| 1 Amounts paid to supported organizations to accomplish exempt purposes | 1 | |
|
2
Amounts paid to perform activity that directly furthers exempt purposes of supported organizations, in excess of income from activity |
2 | |
| 3 Administrative expenses paid to accomplish exempt purposes of supported organizations | 3 | |
| 4 Amounts paid to acquire exempt-use assets | 4 | |
| 5 Qualified set-aside amounts (prior IRS approval required - provide details in Part VI) | 5 | |
| 6 Other distributions (describe in Part VI). See instructions | 6 | |
| 7Total annual distributions. Add lines 1 through 6. | 7 | |
|
8
Distributions to attentive supported organizations to which the organization is responsive (provide details in Part VI). See instructions |
8 | |
| 9 Distributable amount for 2023 from Section C, line 6 | 9 | |
| 10 Line 8 amount divided by Line 9 amount | 10 | |
| Section E - Distribution Allocations (see instructions) |
(i) Excess Distributions |
(ii) Underdistributions Pre-2023 |
(iii) Distributable Amount for 2023 |
|
|---|---|---|---|---|
| 1 Distributable amount for 2023 from Section C, line 6 | ||||
|
2
Underdistributions, if any, for years prior to 2023 (reasonable cause required-- explain in Part VI).
See instructions. |
||||
| 3 Excess distributions carryover, if any, to 2023: | ||||
| a From 2018....... | ||||
| b From 2019....... | ||||
| c From 2020....... | ||||
| d From 2021....... | ||||
| e From 2022....... | ||||
| fTotal of lines 3a through e | ||||
| g Applied to underdistributions of prior years | ||||
| h Applied to 2023 distributable amount | ||||
|
i
Carryover from 2018 not applied (see instructions) |
||||
| j Remainder. Subtract lines 3g, 3h, and 3i from line 3f. | ||||
| 4Distributions for 2023 from Section D, line 7: | ||||
| $ | ||||
| a Applied to underdistributions of prior years | ||||
| b Applied to 2023 distributable amount | ||||
| c Remainder. Subtract lines 4a and 4b from line 4. | ||||
|
5
Remaining underdistributions for years prior to 2023, if any. Subtract lines 3g and 4a from line 2. If the amount is greater than zero, explain in Part VI. See instructions. |
||||
|
6
Remaining underdistributions for 2023. Subtract lines 3h and 4b from line 1. If the amount is greater than zero, explain in Part VI. See instructions. |
||||
|
7 Excess distributions carryover to 2024. Add lines 3j and 4c. |
||||
| 8 Breakdown of line 7: | ||||
| a Excess from 2019..... | ||||
| b Excess from 2020..... | ||||
| c Excess from 2021..... | ||||
| d Excess from 2022..... | ||||
| e Excess from 2023..... | ||||
| Facts And Circumstances Test |
|---|
| Return Reference | Explanation |
|---|
| Software ID: | 23017437 |
| Software Version: | 2023v6.0 |
| Return Reference | Explanation |
|---|---|
| Form 990, Part III, Line 1 ORGANIZATION'S MISSION | THE MISSION OF STANLEY MANNE CHILDREN'S RESEARCH INSTITUTE ("MANNE RESEARCH INSTITUTE") AT ANN & ROBERT H. LURIE CHILDREN'S HOSPITAL OF CHICAGO ("LURIE CHILDREN'S") IS TO GENERATE NEW KNOWLEDGE AND TRANSLATE ADVANCEMENTS IN THE PREVENTION, DIAGNOSIS, AND TREATMENT OF DISEASES THAT AFFECT CHILDREN'S HEALTH THROUGH ADOLESCENCE AND ADULTHOOD. MANNE RESEARCH INSTITUTE'S MULTIDISCIPLINARY TEAMS ARE COMMITTED TO MAKING DISCOVERIES THAT WILL IMPROVE THE LIVES OF CHILDREN AND THEIR FAMILIES. |
| Form 990, Part III, Line 4a PROGRAM SERVICE, LINE 4A | THE MISSION OF STANLEY MANNE CHILDREN'S RESEARCH INSTITUTE ("MANNE RESEARCH INSTITUTE") IS TO GENERATE NEW KNOWLEDGE AND TRANSLATE ADVANCEMENTS IN THE PREVENTION, DIAGNOSIS AND TREATMENT OF DISEASES THAT AFFECT CHILDREN'S HEALTH THROUGH ADOLESCENCE AND ADULTHOOD. MANNE RESEARCH INSTITUTE'S MULTIDISCIPLINARY TEAMS ARE COMMITTED TO MAKING DISCOVERIES THAT WILL IMPROVE THE LIVES OF CHILDREN AND THEIR FAMILIES. MANNE RESEARCH INSTITUTE FACULTY MEMBERS INVESTIGATE A RANGE OF CHILDREN'S HEALTH AND DISEASES ACROSS THE TRANSLATIONAL SCIENCE SPECTRUM. MANNE RESEARCH INSTITUTE'S STUDIES ARE LED BY OVER 750 RESEARCHERS AND STAFF AND ARE ORGANIZED INTO FOUR SCIENTIFIC PILLARS: BASIC AND PRECLINICAL SCIENCE, CLINICAL AND COMMUNITY TRIALS; COMMUNITY, POPULATION HEALTH, AND OUTCOMES; AND QUANTITATIVE SCIENCE. RESEARCHERS AND STAFF INCLUDE PHYSICIANS, SCIENTISTS, POSTDOCS, COORDINATORS, STATISTICIANS, DATA ANALYSTS, TRAINEES, AND OTHERS WHO SHARE THEIR EXPERTISE. THE PEDIATRICIANS AND SCIENTISTS ROUTINELY COLLABORATE WITH LURIE CHILDREN'S ACADEMIC PARTNER, NORTHWESTERN UNIVERSITY, AND OTHER MEDICAL CENTERS AND ACADEMIC INSTITUTIONS ACROSS THE GLOBE, AS WELL AS WITH COMMUNITY PARTNERS SUCH AS SCHOOLS AND GOVERNMENTS. MANNE RESEARCH INSTITUTE RECEIVES EXTERNAL FUNDING ANNUALLY FOR RESEARCH FROM THE NATIONAL INSTITUTES OF HEALTH (NIH) AND OTHER FEDERAL AGENCIES. IT IS ONE OF THE NATION'S PREMIER INSTITUTES FOR PEDIATRIC RESEARCH, INVESTING MORE DOLLARS AND RESOURCES IN PEDIATRIC RESEARCH THAN ANY OTHER AREA HOSPITAL. IN ADDITION TO THE CLINICAL AND POPULATION HEALTH RESEARCH FACILITIES, MANNE RESEARCH INSTITUTE HAS APPROXIMATELY 125,000 SQUARE FEET OF STATE-OF-THE-ART LABORATORY SPACE. THE RESEARCH INSTITUTE'S WET-LAB RESEARCH IS LOCATED IN THE LOUIS A. SIMPSON & KIMBERLY K. QUERREY BIOMEDICAL RESEARCH BUILDING ON NORTHWESTERN UNIVERSITY'S CHICAGO CAMPUS. THE BUILDING INCLUDES WET BENCH LABORATORIES, ANIMAL FACILITIES, AND CONFERENCE, EDUCATIONAL, OFFICE, AND COLLABORATIVE SPACE. MANNE RESEARCH INSTITUTE PILLARS BASIC AND PRECLINICAL SCIENCE RESEARCHERS AT MANNE RESEARCH INSTITUTE CONDUCT LABORATORY EXPERIMENTS THAT INVESTIGATE ESSENTIAL FUNCTIONS OF BIOLOGICAL PROCESSES AND THE FUNDAMENTAL MECHANISMS OF DISEASES AND DISORDERS AFFECTING CHILDREN'S HEALTH. BY CLOSING GAPS IN SCIENTIFIC KNOWLEDGE, BASIC AND PRECLINICAL SCIENCE RESEARCHERS PROVIDE THE FOUNDATION TO DEVELOP NEXT-GENERATION TECHNOLOGIES AND TREATMENTS FOR PEDIATRIC PATIENTS. THE BASIC AND PRECLINICAL SCIENCE PILLAR LABORATORY-BASED PROGRAMS ARE ORGANIZED INTO VIRTUAL SCIENTIFIC NEIGHBORHOODS PROMOTING COLLABORATIONS BETWEEN INVESTIGATORS, STAFF, AND TRAINEES. THESE NEIGHBORHOODS INCLUDE: * DEVELOPMENTAL BIOLOGY * ENGINEERED SOLUTIONS FOR HEALTH * FERTILITY AND HORMONE PRESERVATION AND RESTORATION * HOST-MICROBIAL INTERACTIONS, INFLAMMATION, AND IMMUNITY * HUMAN MOLECULAR GENETICS AND PHYSIOLOGY * IMMUNE DEVIATION AND DISEASE * INJURY, REPAIR, AND REGENERATION * MOLECULAR AND TRANSLATIONAL CANCER BIOLOGY * NEUROBIOLOGY * PERINATAL ORIGINS OF DISEASE CLINICAL AND COMMUNITY TRIALS CLINICAL AND COMMUNITY TRIALS RESEARCHERS AT MANNE RESEARCH INSTITUTE TRANSLATE THE MEANINGFUL DISCOVERIES OF BASIC SCIENCE INTO PROMISING CLINICAL APPLICATIONS THROUGH EVALUATION OF NEW DIAGNOSTIC TESTS AND DRUGS, BEHAVIORAL TREATMENTS, AND OTHER INTERVENTIONS TO DETERMINE THEIR EFFECTS ON PEDIATRIC HEALTH. MULTIDISCIPLINARY TEAMS OF RESEARCHERS COLLABORATE TO STUDY COMPLEX CHILDHOOD HEALTH ISSUES IN AREAS SUCH AS CRITICAL CARE, ONCOLOGY, TRANSPLANT MEDICINE, AND NEONATOLOGY. THEIR RESEARCH GENERATES INNOVATION IN THE DIAGNOSES, TREATMENT, AND PREVENTION OF DISEASES AND DISORDERS IN THE PEDIATRIC POPULATION. COMMUNITY, POPULATION HEALTH, AND OUTCOMES COMMUNITY, POPULATION HEALTH, AND OUTCOMES RESEARCHERS AT MANNE RESEARCH INSTITUTE SEEK TO IMPROVE HEALTH, HEALTH CARE DELIVERY, AND ACCESS TO CARE FOR CHILDREN AND YOUTH FROM A BROAD RANGE OF BACKGROUNDS AND ENVIRONMENTS. THESE RESEARCH LEADERS ADVANCE OUR KNOWLEDGE ABOUT THE NATURAL HISTORY, BIOLOGICAL, PSYCHOLOGICAL, SOCIAL, BEHAVIORAL, AND ENVIRONMENTAL CAUSES AND INFLUENCERS OF COMMON AND PROMINENT CHILD HEALTH PROBLEMS. THEIR RESEARCH INFORMS ACTION FOR PATIENTS, FAMILIES, COMMUNITIES, HEALTH SYSTEM LEADERS, AND POLICYMAKERS. MUCH OF THEIR PROGRAM EVALUATION WORK IS CONDUCTED IN PARTNERSHIP WITH COMMUNITY-BASED ORGANIZATIONS AS EVIDENCE IS TRANSLATED INTO CLINICAL AND PUBLIC HEALTH INTERVENTIONS. QUANTITATIVE SCIENCE QUANTITATIVE SCIENCE EXPERTS COLLABORATE WITH RESEARCHERS ACROSS MANNE RESEARCH INSTITUTE TO PROVIDE CUTTING-EDGE STATISTICAL AND ANALYTICAL SUPPORT AND COMPUTATIONAL TECHNIQUES TO MAXIMIZE RESEARCH IMPACT AND IMPROVE THE HEALTH OUTCOMES OF PEDIATRIC PATIENTS. THEIR EXPERTISE IN STATISTICS, BIOINFORMATICS, DATABASE ANALYTICS, APPLIED CLINICAL INFORMATICS, AND PREDICTIVE ANALYTICS ENABLES RESEARCHERS TO TEST HYPOTHESES, ANSWER RESEARCH QUESTIONS, AND PURSUE UNDERSTANDING OF BEHAVIORS ACROSS DIFFERENT POPULATIONS. RESEARCH STRATEGY MISSION-ALIGNED, ENGAGING, IMPACTFUL STRATEGIC AREAS * ADVANCED THERAPEUTICS: END-TO-END DIAGNOSTIC DEVELOPMENT WITH EARLY-STAGE TRIALS FOR CHILDREN AND INDIVIDUALIZED THERAPY. * HEALTH@HOME: INNOVATIVE HEALTHCARE DELIVERY AND TECHNOLOGY SOLUTIONS OUTSIDE TRADITIONAL MODELS. * FERTILITY AND HORMONE PRESERVATION: EARLY LIFE FERTILITY PRESERVATION, BIOLOGY, AND TECHNOLOGY. * PERINATAL ORIGINS OF DISEASE: BASIC, TRANSLATIONAL, CLINICAL PRACTICE AND PUBLIC HEALTH RESEARCH FOR DETERMINANTS OF EARLY LIFE HEALTH TRAJECTORIES. * HEALTHY BRAIN: THE BASIS OF AND APPROACHES TO MENTAL, BEHAVIORAL, AND NEUROLOGICAL HEALTH. * GLOBAL HEALTH COLLABORATION: FOSTER INTERNATIONAL COLLABORATIONS TO ADDRESS GLOBAL HEALTH DISPARITIES. |
| Form 990, Part V, Line 2a ALLOCATION OF SALARY EXPENSES | ANN & ROBERT H. LURIE CHILDREN'S HOSPITAL OF CHICAGO ("LURIE CHILDREN'S") PAYS AND ISSUES FORMS W-2 TO EMPLOYEES WHO WORK FOR STANLEY MANNE CHILDREN'S RESEARCH INSTITUTE, EXCEPT FOR PHYSICIANS EMPLOYED BY THEIR RESPECTIVE MEDICAL GROUP. THE ALLOCATION OF THE SALARY COSTS ARE DISCLOSED ON FORM 990, PART IX, STATEMENT OF FUNCTIONAL EXPENSES. |
| Form 990, Part VI, Line 15 EXECUTIVE COMPENSATION | THE AUTHORITY TO REVIEW AND APPROVE EXECUTIVE COMPENSATION HAS BEEN DELEGATED TO THE COMPENSATION COMMITTEE OF CHILDREN'S HOSPITAL OF CHICAGO MEDICAL CENTER ("COMPENSATION COMMITTEE"). THE COMPENSATION COMMITTEE HAS ADOPTED A WRITTEN EXECUTIVE COMPENSATION PHILOSOPHY WHICH IT FOLLOWS WHEN IT REVIEWS AND APPROVES THE COMPENSATION AND BENEFITS OF THE ORGANIZATION'S SENIOR MANAGEMENT, INCLUDING THE PRESIDENT. THE COMPENSATION PHILOSOPHY IS SUBJECT TO PERIODIC REVIEW FOR CONTINUED APPROPRIATENESS BY THE COMPENSATION COMMITTEE. WITH THE ASSISTANCE OF A COMPENSATION CONSULTANT AND INFORMATION FROM A VARIETY OF EXTERNAL SOURCES (SPECIFIED ON SCHEDULE J), THE COMPENSATION COMMITTEE CONFIRMED THE TOTAL AMOUNTS TO BE PAID WERE REASONABLE AND COMPARABLE TO AMOUNTS PAID BY SIMILARLY SITUATED ORGANIZATIONS FOR FUNCTIONALLY SIMILAR POSITIONS. LEGAL COUNSEL ADVISES THE COMPENSATION COMMITTEE WITH RESPECT TO FEDERAL TAX REQUIREMENTS IN SETTING COMPENSATION AND THE ESTABLISHMENT OF THE REBUTTABLE PRESUMPTION OF REASONABLENESS. THE PROCESS FOLLOWED BY THE COMPENSATION COMMITTEE, INCLUDING A DESCRIPTION OF THE DATA RELIED UPON AND THE COMPENSATION COMMITTEE'S DECISIONS, WAS THOROUGHLY AND CONTEMPORANEOUSLY DOCUMENTED. THE COMPENSATION COMMITTEE HAS EXPRESSLY REVIEWED THE REASONABLENESS OF COMPENSATION PAID TO IDENTIFIED EXECUTIVES, AND HAS CONCLUDED, AS THE RESULT OF A PROCESS THAT IS DESIGNED TO QUALIFY FOR THE REBUTTABLE PRESUMPTION OF REASONABLENESS UNDER FEDERAL TAX LAW, THAT ALL SUCH AMOUNTS ARE REASONABLE AND DO NOT EXCEED FAIR MARKET VALUE FOR THE SERVICES PROVIDED. THE COMPENSATION COMMITTEE IS COMPRISED OF MEMBERS OF CHILDREN'S HOSPITAL OF CHICAGO MEDICAL CENTER BOARD OF DIRECTORS WHO HAVE BEEN DETERMINED TO BE DISINTERESTED FOR THESE PURPOSES. THE COMPENSATION COMMITTEE CONDUCTS AN ONGOING AND PERIODIC REVIEW OF THE DISINTERESTED STATUS OF ITS MEMBERS AND WILL TAKE APPROPRIATE ACTION WITH RESPECT TO ANYONE HAVING AN INTEREST WITH RESPECT TO ONE OR MORE EXECUTIVES SO AS TO PRESERVE THE APPLICATION OF THE REBUTTABLE PRESUMPTION OF REASONABLENESS. |
| Form 990, Part VI, Line 6 Classes of members or stockholders | CHILDREN'S HOSPITAL OF CHICAGO MEDICAL CENTER ("MEDICAL CENTER") IS THE ORGANIZATION'S SOLE CORPORATE MEMBER. |
| Form 990, Part VI, Line 7a Members or stockholders electing members of governing body | THE ORGANIZATION'S SOLE CORPORATE MEMBER, CHILDREN'S HOSPITAL OF CHICAGO MEDICAL CENTER, HAS CERTAIN RESERVED POWERS, INCLUDING THE POWER TO APPOINT AND REMOVE ALL DIRECTORS OF THE ORGANIZATION. |
| Form 990, Part VI, Line 7b Decisions requiring approval by members or stockholders | CHILDREN'S HOSPITAL OF CHICAGO MEDICAL CENTER, THROUGH ITS BOARD OF DIRECTORS OR DESIGNATED COMMITTEE, AS THE SOLE CORPORATE MEMBER OF THE ORGANIZATION, HAS CERTAIN RESERVED POWERS WITH RESPECT TO APPOINTMENT AND REMOVAL OF DIRECTORS, APPOINTMENT OF CERTAIN OFFICERS, APPROVAL OF AMENDMENTS TO GOVERNING DOCUMENTS, APPROVAL OF FINANCIAL MATTERS, AND APPROVAL OF SIGNIFICANT TRANSACTIONS INCLUDING, BUT NOT LIMITED TO, MERGER, DISSOLUTION, DISPOSITION OF ASSETS OTHER THAN IN THE ORDINARY COURSE OF BUSINESS, AND CREATION OF SUBSIDIARIES. |
| Form 990, Part VI, Line 11b Review of form 990 by governing body | THE AUDIT AND COMPLIANCE COMMITTEE IS THE COMMITTEE OF THE MEDICAL CENTER BOARD CHARGED WITH THE OVERSIGHT OF AUDIT, TAX AND COMPLIANCE MATTERS FOR THE PARENT AND AFFILIATES. DURING A SPECIAL AUDIT AND COMPLIANCE COMMITTEE MEETING, AND BEFORE FORM 990 WAS FILED, THE COMMITTEE WAS PROVIDED A REVIEW OF FORM 990 BY THE CHIEF FINANCIAL OFFICER ("CFO"). THE CFO AND OUTSIDE TAX ADVISOR ALSO RESPONDED TO THE AUDIT AND COMPLIANCE COMMITTEE MEMBERS' QUESTIONS AND AFFORDED THEM THE OPPORTUNITY FOR DETAILED DISCUSSION OF FORM 990, PRIOR TO THE AUDIT AND COMPLIANCE COMMITTEE TAKING ACTION TO APPROVE THE FILING OF FORM 990. THE ORGANIZATION'S FORM 990 WAS PROVIDED TO THE RESPECTIVE FILING ORGANIZATION'S BOARD FOLLOWING THE COMMITTEE'S APPROVAL. AS PART OF ITS ANNUAL RETURN PREPARATION PROCESS, THE ORGANIZATION, ON AN ONGOING BASIS, CONSULTED ITS TAX CONSULTING FIRM AND OUTSIDE TAX LEGAL COUNSEL, BOTH OF WHICH POSSESS EXPERTISE IN HEALTH CARE AND TAX-EXEMPT RETURN PREPARATION, TO ADVISE AND ASSIST IN THE PREPARATION OF FORM 990. THESE ADVISORS WORKED CLOSELY WITH THE ORGANIZATION'S FINANCE PERSONNEL AND OTHER MEMBERS OF THE ORGANIZATION'S TEAM ASSEMBLED TO PARTICIPATE IN THE PREPARATION OF FORM 990. PRIOR TO PRESENTING FORM 990 TO THE MEDICAL CENTER BOARD'S AUDIT AND COMPLIANCE COMMITTEE, THE ORGANIZATION'S TEAM, INCLUDING ITS ADVISORS, MET FREQUENTLY TO DISCUSS AND REVIEW DRAFTS OF THE FORM. SUBSEQUENT TO THE AUDIT AND COMPLIANCE COMMITTEE REVIEW AND APPROVAL, FORM 990 WAS PROVIDED TO THE RESPECTIVE FILING ORGANIZATION'S BOARD OF DIRECTORS. |
| Form 990, Part VI, Line 12c Conflict of interest policy | ON AN ANNUAL BASIS, CHILDREN'S HOSPITAL OF CHICAGO MEDICAL CENTER (THE "MEDICAL CENTER") AND ITS AFFILIATES (COLLECTIVELY THE "CORPORATION") PROVIDE A COMPREHENSIVE QUESTIONNAIRE TO ITS BOARD MEMBERS, SENIOR MANAGEMENT AND OTHER KEY EMPLOYEES POSING QUESTIONS ABOUT ACTUAL OR POTENTIAL CONFLICTS OF INTEREST. THE MEDICAL CENTER INITIATES FOLLOW UP CONTACT TO THOSE WHO DO NOT RESPOND AND TO CLARIFY RESPONSES, WHERE NECESSARY. THE MEDICAL CENTER REVIEWS EACH DISCLOSURE AND PROVIDES A SUMMARY OF RELEVANT DISCLOSURES FOR THE REVIEW AND APPROVAL OF THE MEDICAL CENTER BOARD'S NOMINATING AND GOVERNANCE COMMITTEE. BOARD MEMBERS, SENIOR MANAGEMENT, AND KEY EMPLOYEES ARE SUBJECT TO AN APPLICABLE MEDICAL CENTER CONFLICT OF INTEREST POLICY AND TO A CODE OF CONDUCT, WHICH INCLUDES THE ONGOING RESPONSIBILITY TO PROMPTLY DISCLOSE CONFLICTS OF INTERESTS OR DUALITY OF INTERESTS TO A DESIGNATED INDIVIDUAL(S). DISCLOSURES ARE PROVIDED TO THE NOMINATING AND GOVERNANCE COMMITTEE OF THE MEDICAL CENTER BOARD OF DIRECTORS, WHICH CONSIDERS ALL CONFLICT AND DUALITY OF INTERESTS ISSUES. IF THE DISINTERESTED MEMBERS OF THE NOMINATING AND GOVERNANCE COMMITTEE HAVE DETERMINED THAT A POTENTIAL OR ACTUAL CONFLICT OF INTEREST OR DUALITY OF INTEREST EXISTS, THE NOMINATING AND GOVERNANCE COMMITTEE SHALL DETERMINE IF PREPARATION OF CONFLICTS MANAGEMENT GUIDELINES WILL SUFFICIENTLY MITIGATE THE POTENTIAL OR ACTUAL CONFLICT OF INTEREST AND/OR DUALITY OF INTEREST. IF THE NOMINATING AND GOVERNANCE COMMITTEE DETERMINES THAT CONFLICTS MANAGEMENT GUIDELINES WILL SUFFICIENTLY MITIGATE THE POTENTIAL OR ACTUAL CONFLICT OF INTEREST AND/OR DUALITY OF INTEREST, THE CHIEF LEGAL OFFICER WILL PREPARE SAID CONFLICTS MANAGEMENT GUIDELINES REGARDING THE PARTICULAR PERSON'S POTENTIAL OR ACTUAL CONFLICT OF INTEREST AND/OR DUALITY OF INTEREST FOR REVIEW, APPROVAL, AND OVERSIGHT BY THE NOMINATING AND GOVERNANCE COMMITTEE. THE CHIEF LEGAL OFFICER SHARES THE CONFLICT MANAGEMENT GUIDELINES WITH THE APPLICABLE PERSON FOLLOWING APPROVAL BY THE NOMINATING AND GOVERNANCE COMMITTEE. THE CONFLICTS MANAGEMENT GUIDELINES MAY REQUIRE ANY OR ALL OF THE ASPECTS BELOW. 1. THE RELEVANT PERSON SHALL RECUSE THEMSELVES FROM ALL OR A PORTION OF THE MEETING OF THE BOARD OR COMMITTEE ON WHICH THE PERSON SERVES WHILE THE PROPOSED CONTRACT, TRANSACTION, OR ARRANGEMENT GIVING RISE TO THE CONFLICT OF INTEREST AND/OR THE SITUATION GIVING RISE TO A DUALITY OF INTEREST IS DISCUSSED. IN ADDITION, THE PERSON SHALL RECUSE THEMSELVES FROM ALL OR A PORTION OF THE MEETING OF THE BOARD OR COMMITTEE ON WHICH THE PERSON SERVES WHILE THE MATTER IS VOTED ON, AND ONLY DISINTERESTED DIRECTORS OR COMMITTEE MEMBERS, AS THE CASE MAY BE, MAY VOTE TO DETERMINE WHETHER TO APPROVE THE CONTRACT, TRANSACTION, ARRANGEMENT, OR SITUATION GIVING RISE TO THE CONFLICT OF INTEREST OR DUALITY OF INTEREST. IN DETERMINING WHETHER AND WHEN TO REQUIRE THE PERSON TO RECUSE THEMSELVES DURING DISCUSSION OF THE PROPOSED CONTRACT, TRANSACTION, OR ARRANGEMENT GIVING RISE TO THE CONFLICT OF INTEREST AND/OR THE SITUATION GIVING RISE TO A DUALITY OF INTEREST, THE DISINTERESTED BOARD DIRECTORS OR COMMITTEE MEMBERS, AS THE CASE MAY BE, SHALL BALANCE THE NEED TO FACILITATE THE DISCUSSION BY HAVING SUCH PERSON ON HAND TO PROVIDE ADDITIONAL INFORMATION WITH THE NEED TO PRESERVE THE INDEPENDENCE OF THE DETERMINATION PROCESS. 2. WITH RESPECT TO A CONFLICT OF INTEREST OR DUALITY OF INTEREST, THE DISINTERESTED MEMBERS OF THE NOMINATING AND GOVERNANCE COMMITTEE SHALL EXERCISE DUE DILIGENCE TO DETERMINE WHETHER THE CONTRACT, TRANSACTION, OR ARRANGEMENT PRESENTED BY THE CONFLICT OF INTEREST OR DUALITY OF INTEREST IS FAIR AND REASONABLE AND IN THE BEST INTEREST TO THE CORPORATION. IN REACHING SUCH DETERMINATION, THE NOMINATING AND GOVERNANCE COMMITTEE SHALL DETERMINE WHETHER THERE ARE ALTERNATIVES TO THE PROPOSED CONTRACT, TRANSACTION OR ARRANGEMENT THAT WOULD NOT GIVE RISE TO A CONFLICT OF INTEREST OR DUALITY OF INTEREST. IF A MORE ADVANTAGEOUS CONTRACT, TRANSACTION, OR ARRANGEMENT THAT WOULD NOT GIVE RISE TO A CONFLICT OF INTEREST OR DUALITY OF INTEREST IS NOT REASONABLY ATTAINABLE UNDER THE CIRCUMSTANCES, THE DISINTERESTED MEMBERS OF THE NOMINATING AND GOVERNANCE COMMITTEE MUST DETERMINE BY A MAJORITY VOTE THAT THE CONTRACT, TRANSACTION, OR ARRANGEMENT PRESENTED BY THE CONFLICT OF INTEREST OR DUALITY OF INTEREST IS FAIR AND REASONABLE AND IN THE BEST INTEREST TO THE CORPORATION BEFORE SUCH CONTRACT, TRANSACTION, OR ARRANGEMENT MAY BE APPROVED FOR EXECUTION BY THE BOARD OF DIRECTORS OF ITS EXECUTIVE COMMITTEE. IF THE NOMINATING AND GOVERNANCE COMMITTEE DETERMINES THAT CONFLICTS MANAGEMENT GUIDELINES WILL NOT SUFFICIENTLY MITIGATE THE POTENTIAL OR ACTUAL CONFLICT OF INTEREST AND/OR DUALITY OF INTEREST, THE NOMINATING AND GOVERNANCE COMMITTEE SHALL DETERMINE THE APPROPRIATE STEPS. THE CHIEF LEGAL OFFICER SHARES THE NOMINATING AND GOVERNANCE COMMITTEE'S DECISION WITH THE APPLICABLE PERSON FOLLOWING APPROVAL BY THE NOMINATING AND GOVERNANCE COMMITTEE. |
| Form 990, Part VI, Line 19 Required documents available to the public | THE ORGANIZATION'S FINANCIAL STATEMENTS ARE PUBLICLY AVAILABLE ONLINE AT WWW.DACBOND.COM. THE ORGANIZATION'S ARTICLES OF INCORPORATION AND ANNUAL REPORTS ARE AVAILABLE THROUGH THE ILLINOIS SECRETARY OF STATE. THE ORGANIZATION ALSO MAKES ITS GENERAL GOVERNING DOCUMENTS AVAILABLE TO THE GENERAL PUBLIC UPON REQUEST. |
| Software ID: | 23017437 |
| Software Version: | 2023v6.0 |